BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35720414)

  • 1. A Japanese Herbal Formula, Daikenchuto, Alleviates Experimental Colitis by Reshaping Microbial Profiles and Enhancing Group 3 Innate Lymphoid Cells.
    Shi Z; Takeuchi T; Nakanishi Y; Kato T; Beck K; Nagata R; Kageyama T; Ito A; Ohno H; Satoh-Takayama N
    Front Immunol; 2022; 13():903459. PubMed ID: 35720414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daikenchuto, a Kampo medicine, regulates intestinal fibrosis associated with decreasing expression of heat shock protein 47 and collagen content in a rat colitis model.
    Inoue K; Naito Y; Takagi T; Hayashi N; Hirai Y; Mizushima K; Horie R; Fukumoto K; Yamada S; Harusato A; Hirata I; Omatsu T; Yoshida N; Uchiyama K; Ishikawa T; Handa O; Konishi H; Wakabayashi N; Yagi N; Ichikawa H; Kokura S; Yoshikawa T
    Biol Pharm Bull; 2011; 34(11):1659-65. PubMed ID: 22040876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth stimulation of Bifidobacterium from human colon using daikenchuto in an in vitro model of human intestinal microbiota.
    Sasaki K; Sasaki D; Sasaki K; Nishidono Y; Yamamori A; Tanaka K; Kondo A
    Sci Rep; 2021 Feb; 11(1):4580. PubMed ID: 33633259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer effect of a Kampo preparation Daikenchuto.
    Nagata T; Toume K; Long LX; Hirano K; Watanabe T; Sekine S; Okumura T; Komatsu K; Tsukada K
    J Nat Med; 2016 Jul; 70(3):627-33. PubMed ID: 27059786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zingiberis Siccatum Rhizoma, the active component of the Kampo formula Daikenchuto, induces anti-inflammatory actions through α7 nicotinic acetylcholine receptor activation.
    Endo M; Hori M; Mihara T; Ozaki H; Oikawa T; Odaguchi H; Hanawa T
    Neurogastroenterol Motil; 2017 Dec; 29(12):. PubMed ID: 28656709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiome biomarkers associated with the gut contraction response elicited by the Japanese traditional medicine daikenchuto.
    Wada Y; Nishiyama M; Uehara H; Sato K; Hamamoto Y; Ogihara H; Nishi A; Asakawa T; Yamamoto M
    Gene; 2022 Jun; 826():146262. PubMed ID: 35257788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MSI2 deficiency in ILC3s attenuates DSS-induced colitis by affecting the intestinal microbiota.
    Li N; Xu S; Zhang S; Zhu Q; Meng X; An W; Fu B; Zhong M; Yang Y; Lin Z; Liu X; Xia J; Wang J; You T; Yan C; Tang H; Zhuang G; Peng Z
    Front Immunol; 2022; 13():963379. PubMed ID: 36713428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional Japanese medicines inhibit compound action potentials in the frog sciatic nerve.
    Matsushita A; Fujita T; Ohtsubo S; Kumamoto E
    J Ethnopharmacol; 2016 Feb; 178():272-80. PubMed ID: 26707752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of herbal medicine daikenchuto on gastrointestinal symptoms following laparoscopic colectomy in patients with colon cancer: A prospective randomized study.
    Hanada K; Wada T; Kawada K; Hoshino N; Okamoto M; Hirata W; Mizuno R; Itatani Y; Inamoto S; Takahashi R; Yoshitomi M; Watanabe T; Hida K; Obama K; Sakai Y
    Biomed Pharmacother; 2021 Sep; 141():111887. PubMed ID: 34237597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-colitis and -adhesion effects of daikenchuto via endogenous adrenomedullin enhancement in Crohn's disease mouse model.
    Kono T; Kaneko A; Hira Y; Suzuki T; Chisato N; Ohtake N; Miura N; Watanabe T
    J Crohns Colitis; 2010 Jun; 4(2):161-70. PubMed ID: 21122500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLP-1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells.
    Sun H; Shu J; Tang J; Li Y; Qiu J; Ding Z; Xuan B; Chen M; Gan C; Lin J; Qiu J; Sheng H; Wang C
    Immunology; 2024 Jul; 172(3):451-468. PubMed ID: 38544428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonic vascular conductance increased by Daikenchuto via calcitonin gene-related peptide and receptor-activity modifying protein 1.
    Kono T; Koseki T; Chiba S; Ebisawa Y; Chisato N; Iwamoto J; Kasai S
    J Surg Res; 2008 Nov; 150(1):78-84. PubMed ID: 18561951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rb1 promotes intestinal epithelial wound healing through extracellular signal-regulated kinase and Rho signaling.
    Toyokawa Y; Takagi T; Uchiyama K; Mizushima K; Inoue K; Ushiroda C; Kashiwagi S; Nakano T; Hotta Y; Tanaka M; Dohi O; Okayama T; Yoshida N; Katada K; Kamada K; Ishikawa T; Handa O; Konishi H; Naito Y; Itoh Y
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1193-1200. PubMed ID: 30394577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of the compounds absorbed in human plasma and urine after oral administration of a traditional Japanese (kampo) medicine, daikenchuto.
    Iwabu J; Watanabe J; Hirakura K; Ozaki Y; Hanazaki K
    Drug Metab Dispos; 2010 Nov; 38(11):2040-8. PubMed ID: 20689019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible anti-inflammatory role of Zingiberis processum rhizoma, one component of the Kampo formula daikenchuto, against neutrophil infiltration through muscarinic acetylcholine receptor activation.
    Endo M; Hori M; Ozaki H; Oikawa T; Odaguchi H; Hanawa T
    J Pharmacol Sci; 2018 Aug; 137(4):379-386. PubMed ID: 30145033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Effect of Daikenchuto on Dextran Sulfate Sodium-Induced Colitis in Mice.
    Matsunaga T; Hashimoto S; Yamamoto N; Kawasato R; Shirasawa T; Goto A; Fujisawa K; Takami T; Okamoto T; Nishikawa J; Sakaida I
    Gastroenterol Res Pract; 2017; 2017():1298263. PubMed ID: 28210268
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
    Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
    Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daikenchuto attenuates visceral pain and suppresses eosinophil infiltration in inflammatory bowel disease in murine models.
    Kogure Y; Kanda H; Wang S; Hao Y; Li J; Yamamoto S; Noguchi K; Dai Y
    JGH Open; 2020 Dec; 4(6):1146-1154. PubMed ID: 33319050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Nutrient-sensing Receptor GPRC6A in Regulating Colonic Group 3 Innate Lymphoid Cells and Inflamed Mucosal Healing.
    Hou Q; Huang J; Xiong X; Guo Y; Zhang B
    J Crohns Colitis; 2022 Aug; 16(8):1293-1305. PubMed ID: 35134872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic analysis of daikenchuto, a traditional Japanese medicine (Kampo) in Japanese and US health volunteers.
    Munekage M; Ichikawa K; Kitagawa H; Ishihara K; Uehara H; Watanabe J; Kono T; Hanazaki K
    Drug Metab Dispos; 2013 Jun; 41(6):1256-63. PubMed ID: 23545807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.